TRIALL PROJECT

Our ability to isolate, examine, and measure the effects of chemically active ingredients on the body led to the introduction of modern medicine as we know it.

However, the COVID-19 pandemic shows that society will continue to face medical emergencies as they emerge or re-emerge. Furthermore, finding a solution to a medical condition may mean shifting from one unmet need to another.

A society must find ways to treat diseases that once weren’t treatable into chronic disorders, for instance. Therefore, a steady influx of medical solutions is key to ensuring society’s unmet medical needs are met.

New and improved techniques and technologies are needed to resolve these problems, including drugs, diagnostics, and vaccines. Efficacy and safety of potential medical solutions are systematically evaluated in humans, called clinical trials, under carefully regulated conditions. Medical solutions must be injected into society at a steady and efficient rate if society’s (re)emerging medical needs are to be met. Despite advances in science and technology, drug development speed, prices, and success rates have not improved over time, and in some cases, working circumstances have worsened. Studies show that the cost of drug development continues to rise at an annual rate of about 9%. Moreover, the pace of development is becoming longer and less predictable, which can be seen by the increasing number of changes and delays in projects. There is a negative correlation between these circumstances and the success rate for new candidate medicinal products entering clinical development, with only 11% of them reaching the market.

Ensure data integrity, traceability, and auditability.
- Providing evidence of clinical trial requirements. According to GCP standards, all stakeholders in a clinical trial must keep a record of changes to all trial-related documentation. Sponsors (independent monitors) and regulatory authorities may inspect these records during a trial to ensure the integrity and quality. At the end of the clinical trial process, the documents associated with the investigational product should provide definitive evidence that it is safe and effective and meets regulations for market introduction. A blockchain ledger can function as an immutable and cryptographically secured reference log against which trial-related documents or other data objects can be compared whilst remaining safe in their original, secure(private) repositories.

Using smart contracts to automate
- Monitoring and regulating data exchange and protocol compliance.

Smart contracts built on the blockchain enable new types of automation, with the blockchain serving as the underlying coordinating layer between various off-chain repositories.
Smart contracts can be used in clinical trials to enforce and implement the clinical trial agreement, protocol, and specific contract provisions that control data transactions within a consortium, as well as standard operating procedures (SOPs).

With the use of smart contracts, compliance can be enforced, and key events tracked in near-real-time, thereby preventing protocol deviations or violations from remaining undetected for long periods of time. It serves and connects clinical research professionals across traditional organizational boundaries and domains to build the world's first blockchain-based clinical trial ecosystem.
They enable smarter, safer, and more efficient clinical trials that are guided by integrated workflows, where research data integrity is assured. In order to distinguish themselves from competitors, they will commit to the development of a governance structure, strategy, and roadmap that all support's their core mission.

For further details, kindly visit:
Website: https://triall.io
Whitepaper: https://www.triall.io/wp-content/uploads/2021/04/Triall-Whitepaper-v2.1.pdf
Telegram: https://t.me/triallcommunity
Twitter: https://twitter.com/triallofficial

Bounty0x Username: daveg

“A sponsored article written for a bounty reward”

Related posts:

Tailored Solutions is a Laravel development company and most appropriate for 2019. We have encountered and specialists Laravel developers who are well-familiar with every one of the parts of the…

Morei quase a minha vida toda no mesmo lugar. Quando finalmente me mudei, me emporcalhei de expectativas a cerca de como o lugar novo seria, mais precisamente, de como as pessoas seriam. Bateram…

According to Heidi Horsley, PsyD, executive director and creator of the Open to Hope Foundation, a nonprofit organization that supports people through grief and loss, saying goodbye to a parent is a…